it will be interesting to see of course how this compares to Mesoblast. MSB showed great early promise in its COVID-19 trial, to only be stopped early by the DSMB concluding that it wasn't going to meet its primary end points.
The other issue is that if it does have statistically significantly results, whether it can get emergency approval without going to Phase 2b or Phase 3
- Forums
- ASX - By Stock
- IMM
- Ann: Phase II study for eftilagimod alpha in COVID-19 advances
Ann: Phase II study for eftilagimod alpha in COVID-19 advances, page-10
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
34.0¢ | 36.0¢ | 33.5¢ | $2.184M | 6.253M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 156342 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 107414 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 156342 | 0.345 |
8 | 173610 | 0.340 |
5 | 216592 | 0.335 |
11 | 170484 | 0.330 |
5 | 23066 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 107414 | 4 |
0.355 | 87437 | 2 |
0.360 | 96232 | 4 |
0.365 | 117195 | 6 |
0.370 | 119996 | 5 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |